Jubilant Life Sciences Ltd. announced that it has given notice to the holders of its USD 300,000,000 4.875% Senior Notes due 2021 that it has elected to exercise its option to redeem USD 100,000,000 in aggregate principal amount of the Notes on March 5, 2021 pursuant to the terms of the indenture dated as of October 6, 2016 between JPL and The Bank of New York Mellon, London Branch as trustee, governing the Notes. JPL had made the first early redemption of USD 100,000,000 in November 2019 and the second early redemption of USD 100,000,000 on January 29, 2021, and following the proposed redemption of USD 100,000,000 on March 5, 2021, the Notes will be paid in full and no amount will remain outstanding under the Notes.